Reaction
Acute Polyneuropathy reporting signals
As of the last recalculation, Acute Polyneuropathy appears in 277 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is BRENTUXIMAB VEDOTIN (PRR 99.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Brentuximab Vedotin | 13 | 99.9 | 100.1 |
| Mesna Injection | 10 | 94.3 | 94.4 |
| Mesna | 10 | 92.6 | 92.7 |
| Trametinib | 14 | 45.8 | 45.8 |
| Dabrafenib | 12 | 44.7 | 44.7 |
| Aprepitant | 10 | 42.2 | 42.2 |
| Thiotepa | 5 | 40.0 | 40.1 |
| Encorafenib | 4 | 30.8 | 30.8 |
| Panitumumab | 5 | 24.4 | 24.4 |